Unveiling the DHX15-G-patch interplay in retroviral RNA packaging.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 25 9 2024
pubmed: 25 9 2024
entrez: 25 9 2024
Statut: ppublish

Résumé

We explored how a simple retrovirus, Mason-Pfizer monkey virus (M-PMV) to facilitate its replication process, utilizes DHX15, a cellular RNA helicase, typically engaged in RNA processing. Through advanced genetic engineering techniques, we showed that M-PMV recruits DHX15 by mimicking cellular mechanisms, relocating it from the nucleus to the cytoplasm to aid in viral assembly. This interaction is essential for the correct packaging of the viral genome and critical for its infectivity. Our findings offer unique insights into the mechanisms of viral manipulation of host cellular processes, highlighting a sophisticated strategy that viruses employ to leverage cellular machinery for their replication. This study adds valuable knowledge to the understanding of viral-host interactions but also suggests a common evolutionary history between cellular processes and viral mechanisms. This finding opens a unique perspective on the export mechanism of intron-retaining mRNAs in the packaging of viral genetic information and potentially develop ways to stop it.

Identifiants

pubmed: 39320912
doi: 10.1073/pnas.2407990121
doi:

Substances chimiques

RNA, Viral 0
RNA Helicases EC 3.6.4.13
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2407990121

Subventions

Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy (MŠMT)
ID : LX22NPO5103
Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy (MŠMT)
ID : 90254

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Alžběta Dostálková (A)

Department of Biotechnology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.

Ivana Křížová (I)

Department of Biotechnology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.

Petra Junková (P)

Institute of Organic Chemistry and Biochemistry Research Centre & Gilead Sciences, Czech Academy of Sciences, 166 10 Prague, Czech Republic.
Department of Biochemistry and Microbiology, University of Chemistry and Technology 166 28, Prague, Czech Republic.

Jana Racková (J)

Department of Biotechnology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.

Marina Kapisheva (M)

Department of Biotechnology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.

Radim Novotný (R)

Department of Biochemistry and Microbiology, University of Chemistry and Technology 166 28, Prague, Czech Republic.

Matěj Danda (M)

Department of Biotechnology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.

Karolína Zvonařová (K)

Department of Biotechnology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.

Larisa Šinkovec (L)

Department of Biotechnology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.

Kateřina Večerková (K)

Department of Informatics and Chemistry, University of Chemistry and Technology, 166 28 Prague, Czech Republic.
Institute of Molecular Genetics, Czech Academy of Sciences, 142 20 Prague, Czech Republic.

Lucie Bednářová (L)

Institute of Organic Chemistry and Biochemistry Research Centre & Gilead Sciences, Czech Academy of Sciences, 166 10 Prague, Czech Republic.

Tomáš Ruml (T)

Department of Biochemistry and Microbiology, University of Chemistry and Technology 166 28, Prague, Czech Republic.

Michaela Rumlová (M)

Department of Biotechnology, University of Chemistry and Technology, 166 28 Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH